Search companies or stocks...
CNTXContext Therapeutics Inc.
At close · 02 Sept 2026, 08:00 pm
Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.
Context Therapeutics Inc., a clinical-stage biopharmaceutical company, develops products for the treatment of cancer for women in the United States. Its lead product…
Current stock price of Context Therapeutics Inc. (CNTX) stock is $0.360. The stock price is -0.44% lower in the session. The intraday range can be seen from this page. Volume of Context Therapeutics Inc. (CNTX) stock is 1.31M.
Last updated at 02 Sept 2026, 08:00 pm.
The stock price of Context Therapeutics Inc. (CNTX) can change with earnings, company news, and overall market sentiment. Context Therapeutics Inc. operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.
Whether Context Therapeutics Inc. looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for CNTX on this page is -0.76. EPS on this page is -0.48. Compare those figures with peers and growth expectations before deciding if the current Context Therapeutics Inc. price is justified.
Historical performance for Context Therapeutics Inc. (CNTX) is shown on the price chart on this page. Review multi-period moves alongside volume to see how CNTX reacted to past earnings and market events.
Buying Context Therapeutics Inc. (CNTX) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.
